Sattar, NaveedRefine your research by the most used items
Author / Editor
- Gabay, Cem (2)
- Aboyans, Victor (1)
- Bailey, Clifford J (1)
- Betteridge, Neil (1)
- Bingham, Clifton O (3rd) (1)
- Breedveld, Ferdinand C (1)
- Burmester, Gerd R (1)
- Bykerk, Vivian (1)
- Ceriello, Antonio (1)
- Choy, Ernest H (1)
Document type
Full text accessibility
Full text version
Subject
- Antibodies, monoclonal, humanized/administration & dosage/adverse effects (1)
- Antirheumatic agents/administration & dosage/adverse effects (1)
- Arthritis, rheumatoid/drug therapy/immunology (1)
- Cardiovascular diseases (1)
- Cardiovascular risk assessment (1)
- Diabetes mellitus (1)
- Drug monitoring/methods (1)
- Epidemiology (1)
- Guidelines (1)
- Humans (1)
Highlights
Show items per page
remove all| Title | Authors / Editors | Date | |
|---|---|---|---|
 |
Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions | Smolen, Josef S; Schoels, Monika M; Nishimoto, Norihiro; Breedveld, Ferdinand C; ... van der Heijde, Désirée | 2013 |
|
|
Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis | Gabay, Cem; McInnes, Iain B; Kavanaugh, Arthur; Tuckwell, Katie; ... Sattar, Naveed | 2016 |
|
|
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. | Cosentino, Francesco; Grant, Peter J; Aboyans, Victor; Bailey, Clifford J; ... Wheeler, David C | 2020 |
